Caribou Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Caribou Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
  • Caribou Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $4.74M, a 32.2% increase year-over-year.
  • Caribou Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $15.8M, a 26.2% increase year-over-year.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.8M, a 17.4% increase from 2022.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.7M, a 240% increase from 2021.
  • Caribou Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.45M, a 244% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $15.8M $4.74M +$1.15M +32.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $14.6M $3.99M +$857K +27.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $13.8M $3.56M +$455K +14.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-11
Q3 2023 $13.3M $3.48M +$805K +30.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $12.5M $3.59M +$667K +22.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $11.8M $3.13M +$107K +3.54% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $11.7M $3.1M +$1.52M +96.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-11
Q3 2022 $10.2M $2.67M +$1.74M +186% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $8.46M $2.92M +$2.33M +392% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $6.13M $3.02M +$2.68M +782% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $3.45M $1.58M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $935K +$687K +277% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $593K +$307K +107% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $343K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $248K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $286K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.